Monday, June 26, 2017

Vineti Gets $13.75M For Pharmaceuticals Software

San Francisco-based Vineti, a developer of software aimed at use in cell and gene therapy, has raised $13.75M in a Series A funding, the company said last week. The funding came from GE Ventures, Mayo Clinic Ventures, DFJ and LifeForce Capital. The company said it is developing software to accelerate delivery of individualized cell therapy for treating cancer. Amy DuRoss is CEO at Vineti.